Aspirin reduces the incidence of metastatic Braf mutant colorectal cancer in a preclinical trial

被引：0
|
作者：
Kane, A. [1 ,2 ,3 ]
Mckeone, D. [1 ]
Liu, C. [1 ,2 ]
Borowsky, J. [1 ,2 ,3 ]
Leggett, B. [1 ,2 ,4 ]
Whitehall, V. [1 ,2 ,3 ]
机构：
[1] QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia
[2] Univ Queensland, Brisbane, Qld, Australia
[3] Pathol Queensland, Brisbane, Qld, Australia
[4] Royal Brisbane & Womens Hosp, Brisbane, Qld, Australia
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2019年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
213
引用
收藏
页码：33 / 33
页数：1
相关论文
共 50 条
  • [41] RAS and BRAF in metastatic colorectal cancer management
    Gong, Jun
    Cho, May
    Fakih, Marwan
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2016, 7 (05) : 687 - 704
  • [42] Binimetinib, encorafenib and cetuximab (BEACON Trial) combination therapy for patients with BRAF V600E-mutant metastatic colorectal cancer
    Shahjehan, F.
    Kamatham, S.
    Chandrasekharan, C.
    Kasi, P. M.
    DRUGS OF TODAY, 2019, 55 (11) : 683 - 693
  • [43] BRAF mutant metastatic colorectal cancers: new arrows in our quiver
    Cremolini, Chiara
    Moretto, Roberto
    Zucchelli, Gemma
    Falcone, Alfredo
    ANNALS OF TRANSLATIONAL MEDICINE, 2019, 7
  • [44] Molecular mechanisms underlying the resistance of BRAF V600E-mutant metastatic colorectal cancer to EGFR/BRAF inhibitors
    Xu, Ting
    Wang, Xicheng
    Wang, Zhenghang
    Deng, Ting
    Qi, Changsong
    Liu, Dan
    Li, Yanyan
    Ji, Congcong
    Li, Jian
    Shen, Lin
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2022, 14
  • [45] Seeking therapeutic synergy in BRAF mutant colorectal cancer
    Elena Elez
    Javier Ros
    Josep Tabernero
    Nature Medicine, 2023, 29 : 307 - 308
  • [46] Hitting the Target in BRAF-Mutant Colorectal Cancer
    Nagaraja, Ankur K.
    Bass, Adam J.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (34) : 3990 - +
  • [47] Seeking therapeutic synergy in BRAF mutant colorectal cancer
    Elez, Elena
    Ros, Javier
    Tabernero, Josep
    NATURE MEDICINE, 2023, 29 (02) : 307 - 308
  • [48] Targeted therapy for BRAF-mutant colorectal cancer
    Gunjur, Ashray
    LANCET ONCOLOGY, 2019, 20 (11): : E618 - E618
  • [49] Resistance to RAF Inhibition in BRAF Mutant Colorectal Cancer
    Corcoran, Ryan B.
    ONCOLOGIST, 2012, 17 : 2 - 2
  • [50] BRAF Inhibitor Dabrafenib in Patients with Metastatic BRAF-Mutant Thyroid Cancer
    Falchook, Gerald S.
    Millward, Michael
    Hong, David
    Naing, Aung
    Piha-Paul, Sarina
    Waguespack, Steven G.
    Cabanillas, Maria E.
    Sherman, Steven I.
    Ma, Bo
    Curtis, Martin
    Goodman, Vicki
    Kurzrock, Razelle
    THYROID, 2015, 25 (01) : 71 - 77
12345